Linus Health

If someone is showing signs of dementia, it’s important to see a medical expert who can conduct tests and come up with a diagnosis. AARP shares methods for diagnosing the disease, including cognitive and neuropsychological tests that assess language and math skills, memory, problem-solving and other types of mental functioning. While primary care physicians agree these tests are important to diagnose mild cognitive impairment (MCI), many have found it’s difficult to do so. The top-reported challenges include difficulty distinguishing MCI from normal aging, difficulty interpreting patient reports of daily functioning, and lack of expertise in performing cognitive assessments. New AI-powered solutions that leverage cutting-edge neuroscience and clinical expertise are making it easier for providers to accelerate early detection of dementia. These technologies additionally provide clinical decision support alongside patient results and generate personalized action plans for patients -- aiding providers to navigate next steps and support patients with evidence-based guidance. https://bit.ly/3Wo8Smo I #EarlyDetection #BrainHealth #Dementia #DementiaDetection #AlzheimersDisease

Linus Health Chief Strategy Officer John Showalter recently spoke with Authority Magazine to share why the right lifestyle habits can be the cornerstone to maintaining and even enhancing our cognitive abilities. Dr. Showalter shares five lifestyle habits that support cognitive well-being:   🏃♂️ Getting exercise 🤝 Maintaining social interaction  👂 Addressing hearing impairment 🛌 Ensuring sufficient sleep 👩⚕️  Getting proactively assessed by a doctor Dementia is a top concern for those over 65. It's crucial to talk to a doctor and get screened, even for reassurance and to reduce anxiety. Being proactive about cognitive health and seeking information and assessments from doctors is essential. 🧠✨ https://lnkd.in/gZwJAG7M I #EarlyDetection #BrainHealth #Dementia #DementiaDetection #AlzheimersDisease Medium

Linus Health will be in Anaheim July 18-20 for Pri-Med West! Designed for clinicians in primary care, family medicine, and internal medicine, we invite attendees to stop by booth #630 to learn how the Linus Health platform — a suite of digital cognitive assessment, clinical decision support, and intervention solutions — can enable your medical group or health system to: 🧠 Meet the rising cognitive care needs of older adults 🧠 Streamline testing for early signs of Alzheimer's disease and other dementias 🧠 Deliver robust clinical insights to inform care pathways #AlzheimersAwareness #AlzheimersDisease #PrimaryCare #PriMedWest #PriMedWest2024

With the recent FDA approval of Eli Lilly and Company’s drug donanemab, along with the growing number of other Alzheimer’s and dementia drugs becoming available, it’s crucial to identify patients early enough to benefit from these life-changing medications. At Linus Health, we strive to move the detection timeline forward. Our platform can identify the risk of cognitive impairment years before clinical symptoms appear, preserving more brain function and promoting better long-term functional independence. Time equals neurons! 🧠 #AlzheimersDisease #EarlyDetection #Dementia #BrainHealth #FDAApprovals #donanemab

FDA has approved Eli Lilly’s drug donanemab, which will be marketed as Kisunla. This drug is indicated for the treatment of early symptomatic Alzheimer's disease, which includes people with mild cognitive impairment (MCI) as well as those with the mild dementia stage of Alzheimer’s with confirmed amyloid pathology. Once-monthly Kisunla is the first amyloid plaque-targeting therapy with evidence to support stopping therapy if and when amyloid plaques are removed, setting the stage for potentially lower treatment costs and fewer infusions. Ryan Cross of Endpoints News reports that people living with Alzheimer’s disease and their families will now have the choice of two treatments designed to clear sticky amyloid proteins in the brain and slow the progression of the disease, albeit modestly. The approval of Kisunla kick-starts a competition between Indianapolis-based Lilly, and Eisai and Biogen, which won full approval last year for their treatment Leqembi, which is indicated for the treatment of Alzheimer's in patients with MCI or the mild dementia stage of disease. Linus Health views the growing arsenal of drugs to treat earlier-stage cognitive impairment as a step in the right direction, especially when combined with digital screenings starting at age 55 to detect mild cognitive impairment when lifestyle interventions and potential drug therapy can make the most difference. Read more here: https://bit.ly/3L9U0BR | #Kisunla #AlzheimersDisease #EarlyDetection #Dementia #BrainHealth #FDAApprovals

Healthcare IT Today recently talked with Linus Health’s David Bates and John Showalter to learn more about how AI-driven predictive analytics and machine-learning algorithms are being employed to streamline hospital operations, optimize resource allocations, and improve overall healthcare system efficiency. At Linus Health, our groundbreaking digital cognitive assessment platform brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. It provides an efficient, scientifically validated solution for detecting signs of cognitive impairment early and opening up a new window of opportunity for action. Read more: https://lnkd.in/d5yUUQYm I #AlzheimersResearch #AlzheimersDisease #EarlyDetection #ArtificialIntelligence #AI #Dementia

Alzheimer's Disease and related dementias are increasing, with African Americans twice as likely to develop dementia than other ethnic populations. However, current cognitive screening methods lack the sensitivity to effectively identify those at risk. New research published in Frontiers in Aging Neuroscience demonstrates the DCTclock’s ability to estimate the 5-year risk of developing dementia in an African American population. Early detection of dementia risk using the DCTclock can also: 1️⃣ Enhance participant selection in clinical trials while reducing screening costs. 2️⃣ Provide patients, caregivers, and clinicians opportunities to plan and intervene early to improve cognitive health trajectories. https://lnkd.in/g36P2dpa I #AlzheimersResearch #AlzheimersDisease #Early Detection #CognitiveDecline #Dementia

This is not your average #Alzheimers meeting 😂 what better place to talk about #brainhealth than with 10,000 future #healthprofessionals! Its never too late, and its never too early! HOSA-Future Health Professionals Linus Health Curt J. Thornton John Showalter Meredith Steffen

In the most recent installment of the Passionate Pioneers Podcast, Linus Health CEO and Co-Founder David Bates discusses his mission to advance brain health by making early detection of cognitive disorders accessible to everyone. 🎧 Tune in now to hear more about: ▶ The formation of Linus Health, inspired by Bates’ fascination with the brain and a pivotal conversation with a cognitive neurologist, leading to the company's founding in June 2019. ▶ Linus Health’s use of AI, sensors, and advanced analytics to deliver brain health insights and action plans, enabling people to take agency over their brain health and live their best lives. ▶ How we are addressing a critical gap in healthcare, with 92% of mild cognitive impairment (MCI) cases currently undiagnosed and potentially long wait times for specialist care. ▶ How Bates envisions a future where brain health is given as much importance as heart health in standard care. https://lnkd.in/gjjvyYzN I #AlzheimersDisease #EarlyDetection #DigitalHealth #Dementia

We are pleased to announce that Linus Health’s clinical and research leaders have co-authored a peer-reviewed article describing a technology-enabled, scalable approach to guide clinical decisions and outcome evaluations about brain health that effectively incorporate patients’ treatment priorities. While patients may have the same neurodegenerative disease, the aspects of life that are clinically meaningful differ across diverse patient backgrounds and values. The perspective paper, published in Frontiers in Neurology, describes why and how using an evidence-based tool efficiently incorporates patients’ input to both monitor and support outcomes that truly matter to them in the long term. Read more in today’s press release: https://bit.ly/3xtLGd1 I #AlzheimersDisease #AlzheimersResearch #EarlyDetection #BrainHealth